Transitioning from Propranolol to Metoprolol (Taper-Based Conversion)
Transitioning should be performed using beta-blocker dose equivalence to initiate metoprolol while tapering propranolol to avoid abrupt cessation. Abrupt beta-blocker withdrawal should be avoided due to risk of beta-adrenergic supersensitivity and rebound symptoms. [1], [2]
Medication Selection Algorithm
- Select metoprolol formulation based on the clinical target and the intended dosing frequency.
- Metoprolol immediate-release (metoprolol IR) is used on a twice-daily schedule in common conversion tables. [1]
-
Metoprolol SR is used on a once-daily schedule in common conversion tables. [1]
-
Use beta-blocker dose equivalence between propranolol IR and metoprolol IR for starting metoprolol dosing during the switch. [1]
Beta-Blocker Dose Conversion
- Propranolol IR 40 mg twice daily corresponds to metoprolol IR 50 mg twice daily (sample equivalency in a hospital conversion table). [1]
- Proportional conversion across doses should be applied using the above equivalency as the basis for calculating the metoprolol total daily dose. [1]
Overlapping Switch and Taper Plan
- Metoprolol should be initiated at the calculated equivalent dose when propranolol dose reduction begins. [1]
- Propranolol tapering should be performed over 7 to 14 days to avoid withdrawal symptoms. [3]
- A minimum of 14 days is suggested for chronic use to reduce withdrawal risk. [3]
Monitoring During Transition
- Blood pressure and pulse should be checked during withdrawal/tapering to detect rebound tachycardia or hypertension. [2], [3]
- Additional clinical monitoring should be performed for re-emergence of the original indication (eg, angina or migraine prophylaxis) and for bradycardia or hypotension after metoprolol initiation. [1], [3]
Initiation Thresholds and When Slower Conversion Is Required
- Faster conversion should be avoided in patients receiving higher propranolol doses or with prolonged exposure due to higher likelihood of withdrawal complications. [3]
- Specialist input should be sought when propranolol dosing is high or when tapering cannot be individualized safely. [3]
Common Pitfalls to Avoid
- Abrupt propranolol discontinuation should be avoided because it can precipitate withdrawal symptoms from beta-adrenergic supersensitivity. [2], [3]
- Switching metoprolol dosing without using documented beta-blocker equivalence should be avoided because underdosing can increase rebound risk and overdosing can cause bradycardia or hypotension. [1], [3]
Target Outcomes of the Transition
- The transition goal should be maintenance of adequate beta-blockade to prevent rebound symptoms while achieving metoprolol steady dosing. [1], [3]
- Heart rate and blood pressure stability during and after propranolol taper should be the primary safety outcomes during conversion. [2], [3]